RMD — RESMED INC

Ownership history in Newfound Research LLC  ·  8 quarters on record

This page tracks every 13F SEC filing in which Newfound Research LLC reported a position in RESMED INC (RMD). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.

Peak position
0.22% (2022 Q3)
Avg. % of fund
0.17%
First filed
2020 Q3
Last filed
2022 Q3
Quarters held
8
Quarter Action Shares Change Chg % % of Fund Mkt Value Price (EOQ)
2022 Q3 REDUCED 410 -57 -12.2% 0.22% $90K $211.38
2022 Q2 REDUCED 467 -43 -8.4% 0.21% $98K $202.60
2022 Q1 ADDED 510 +250 +96.2% 0.16% $124K $233.88
2021 Q3 REDUCED 260 -136 -34.3% 0.11% $69K $253.32
2021 Q2 ADDED 396 +18 +4.8% 0.19% $98K $236.60
2021 Q1 REDUCED 378 -20 -5.0% 0.17% $73K $185.84
2020 Q4 ADDED 398 +229 +135.5% 0.22% $85K $203.20
2020 Q3 INITIATED 169 — — 0.08% $29K $163.59
% of Fund (quarterly)    RMD price (monthly, adj. close)

Other funds also holding RMD

As of 2025 Q4 — sorted by position size

BlackBarn Capital Partners LP 6.34% 2Xideas AG 3Y 5.01% Tandem Investment Advisors, Inc. 3Y 7Y 4.49% Dundas Partners LLP 3Y 7Y 3.48% AMERICAN CAPITAL MANAGEMENT INC 3Y 7Y 3.26% Birch Capital Management, LLC 3Y 3.23% XY Capital Ltd 3Y 3.11% Capital Impact Advisors, LLC 3Y 7Y 3.0% Capital Investment Services of America, Inc. 3Y 7Y 2.61% Eukles Asset Management 3Y 7Y 2.13%
← Back to Newfound Research LLC Holdings